Iovance Biotherapeutics Short and Long Term Debt Total History
| IOVA Stock | USD 3.44 -0.04 -1.15% |
Short and Long Term Debt Total | First Reported 2011-09-30 | Previous Quarter 52.5 M | Current Value 48.4 M | Quarterly Volatility 32.5 M |
Macro event markers
Latest Iovance Biotherapeutics Short and Long Term Debt Total Growth Pattern
| Short and Long Term Debt Total | 10 Years Trend |
|
Short Long Term Debt Total |
| Timeline |
Short and Long Term Debt Total Trend Statistics
Over 9 reporting periods, Iovance Biotherapeutics' Short and Long Term Debt Total shows a coefficient of variation of 92.1%, indicating wide dispersion driven primarily by directional growth rather than instability. An R-squared of 0.64 points to a strong linear fit indicating consistent directional movement.| Arithmetic Mean | 31,143,453 | |
| Geometric Mean | 19,368,806 | |
| Coefficient Of Variation | 92.10 | |
| Mean Deviation | 25,820,239 | |
| Median | 11,500,000 | |
| Standard Deviation | 28,682,243 | |
| Sample Variance | 822.7T | |
| Range | 80.4M | |
| R-Value | 0.80 | |
| Mean Square Error | 319.4T | |
| R-Squared | 0.64 | |
| Significance | 0.0001 | |
| Slope | 4,529,586 | |
| Total Sum of Squares | 13162.7T |
Iovance Biotherapeutics Short and Long Term Debt Total History
The table below covers 9 reported values for Iovance Biotherapeutics' Short and Long Term Debt Total, from 6.5 M (2012) to 46.3 M (2026).Correlation of Short and Long Term Debt Total With Other Accounts
Correlation values indicate the degree of linear co-movement between Iovance Biotherapeutics' Short and Long Term Debt Total and other reported accounts. Values near +1 or −1 suggest strong association; values near 0 suggest independence. These relationships are descriptive and do not imply causation.Click cells to compare fundamentals
Related Fundamentals
| Last Reported | End Of Year Estimate | ||
| Cash And Short Term Investments | 297 M | 243.5 M | |
| Short Term Investments | 133.9 M | 188.1 M | |
| Short Term Debt | 4 M | 8 M | |
| Short and Long Term Debt | 900 K | 800 K | |
| Short Term Coverage Ratios | -86.02 | -81.72 |
Methodology, Assumptions & Data Sources
The data below presents Iovance Biotherapeutics's Short and Long Term Debt Total through recent fiscal years. Sequential period comparisons surface inflection points that rolling averages can obscure. For Iovance Biotherapeutics in the Biotechnology sector, Short and Long Term Debt Total captures the scale of obligations used to fund operations and growth.
Reported values for Iovance Biotherapeutics are derived from periodic company reporting and market reference feeds and standardized for analysis. Sell-side coverage, where present, supplements the data shown. Reference data and historical patterns are presented and do not constitute an investment recommendation or advice.
Editorial review and methodology oversight provided by: Ellen Johnson, Member of Macroaxis Editorial Board